Journal of Antivirals & Antiretroviral is one of the best journals in virology field. All the contents published in this journal are innovative and updated as per the current trend modifications with the development in the technologies and feels new. The main aim of the journal is to provide all the latest information of the latest fields
Virosomes study mainly studies the treatment for HIV or AIDS. It is not a cure, but with antiretroviral therapy we can stop people from becoming ill for many years. A virosome is a drug or vaccine delivery mechanism consisting of unilamellar phospholipid membrane it may be mono- or bi-layered. Vesicle incorporating virus derived proteins to allow the virosomes to fuse with target cells. Virosomes are not able to replicate but are pure fusion-active vesicles.
The development of safe and effective models for the delivery of any prophylactic or therapeutic agent remains an uphill task for pharmaceutical formulation developers. Drug molecules, nucleic acids, carbohydrates, proteins and a variety of other biological and chemical entities are used for attaining pharmacological benefits. However, the major challenge remains in the delivery of these agents to the specific site of action in a time-efficient manner. Among the many drug delivery systems developed, the nano scale technology of virosomes tends to present an established system of delivering the therapeutic agents to the site of pharmacological action. Virosomes are lipid bilayer, unilamellar structures that present viral protein on their surface. They are safe, biocompatible and biodegradable structures that can achieve ideal pharmacological profile once administered into the body. Tissue targeting, immune activation and potentiation are the chief advantages that make them efficient prophylactic and therapeutic agents. The review presents the biopharmaceutical applications of virosomes and the immunological and pharmaceutical considerations that make them efficient agents for targeting spatiotemporal parameters in the body.
OMICS Group is among the leading open access publishers with around 700+ peer-reviewed journals with several best quality peer-reviewed articles. It has more than 50,000+ editorial board members in its Editorial Board and many expert reviewers to carry rigorous peer-review process. Apart from this OMICS Group organizes more than 3000+ International Scientific Conferences across the globe. OMICS Group is having support of more than 1000+ Scientific associations, 50,000+ editorial board members and 15 million readers.
Last date updated on May, 2021